- Home
- GEHC
as 12-20-2024 4:00pm EST
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
| Founded: | 1892 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 37.5B | IPO Year: | N/A |
| Target Price: | $95.46 | AVG Volume (30 days): | 3.3M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.65 | EPS Growth: | 8.27 |
| 52 Week Low/High: | $71.31 - $94.55 | Next Earning Date: | 02-13-2025 |
| Revenue: | $19,559,000,000 | Revenue Growth: | 1.43% |
| Revenue Growth (this year): | 2.72% | Revenue Growth (next year): | 4.08% |
Stock Insider Trading Activity of GE HealthCare Technologies Inc. (GEHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Rott Roland | GEHC | CEO, Imaging | Nov 5 '24 | Sell | $86.48 | 3,577 | $309,338.96 | 24,298 | |
| Rackliffe Philip | GEHC | CEO, AVS | Nov 5 '24 | Sell | $87.63 | 900 | $78,867.00 | 12,715 |
Latest GE HealthCare Technologies Inc. News
GEHC Breaking Stock News: Dive into GEHC Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
An Intrinsic Calculation For GE HealthCare Technologies Inc. (NASDAQ:GEHC) Suggests It's 36% Undervalued
Business Wire
10 days ago
GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025
Simply Wall St.
15 days ago
Possible Bearish Signals With GE HealthCare Technologies Insiders Disposing Stock
Business Wire
17 days ago
GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide
Business Wire
18 days ago
GE HealthCare showcases commitment to sustainable innovation at RSNA 2024
Business Wire
19 days ago
GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction
Business Wire
20 days ago
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
Business Wire
20 days ago
GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI
Compare GEHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GEHC GE HealthCare Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.